Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Davis

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|June 9, 1979
Survey of operating room pollution within an N.H.S. districtM M Halliday, K B Carter, P D Davis, et al.
Agents and Actions|March 1, 1991
Modulation of cellular processes by H7, a non-selective inhibitor of protein kinasesJ S Nixon, S E Wilkinson, P D Davis, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|October 1, 1995
The national jockey injury study: an analysis of injuries to professional horse-racing jockeysJ M Press, P D Davis, S L Wiesner, et al.
Immunity|November 9, 2000
Inhibition of amyloid fiber assembly by both BiP and its target peptideP D Davis, R Raffen, L J Dul, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
K252a is a potent and selective inhibitor of phosphorylase kinaseL H Elliott, S E Wilkinson, A D Sedgwick, et al.
Journal of Medicinal Chemistry|January 1, 1992
Inhibitors of protein kinase C. 1. 2,3-BisarylmaleimidesP D Davis, C H Hill, G Lawton, et al.
FEBS Letters|December 18, 1989
Potent selective inhibitors of protein kinase CP D Davis, C H Hill, E Keech, et al.
Journal of Medicinal Chemistry|January 8, 1993
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restrictionR A Bit, P D Davis, L H Elliott, et al.
Drugs Under Experimental and Clinical Research|January 1, 1991
Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activityJ S Nixon, J Bishop, D Bradshaw, et al.
Biochemical Society Transactions|May 1, 1992
The design and biological properties of potent and selective inhibitors of protein kinase CJ S Nixon, J Bishop, D Bradshaw, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|June 9, 1979
Survey of operating room pollution within an N.H.S. districtM M Halliday, K B Carter, P D Davis, et al.
Agents and Actions|March 1, 1991
Modulation of cellular processes by H7, a non-selective inhibitor of protein kinasesJ S Nixon, S E Wilkinson, P D Davis, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|October 1, 1995
The national jockey injury study: an analysis of injuries to professional horse-racing jockeysJ M Press, P D Davis, S L Wiesner, et al.
Immunity|November 9, 2000
Inhibition of amyloid fiber assembly by both BiP and its target peptideP D Davis, R Raffen, L J Dul, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
K252a is a potent and selective inhibitor of phosphorylase kinaseL H Elliott, S E Wilkinson, A D Sedgwick, et al.
Journal of Medicinal Chemistry|January 1, 1992
Inhibitors of protein kinase C. 1. 2,3-BisarylmaleimidesP D Davis, C H Hill, G Lawton, et al.
FEBS Letters|December 18, 1989
Potent selective inhibitors of protein kinase CP D Davis, C H Hill, E Keech, et al.
Journal of Medicinal Chemistry|January 8, 1993
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restrictionR A Bit, P D Davis, L H Elliott, et al.
Drugs Under Experimental and Clinical Research|January 1, 1991
Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activityJ S Nixon, J Bishop, D Bradshaw, et al.
Biochemical Society Transactions|May 1, 1992
The design and biological properties of potent and selective inhibitors of protein kinase CJ S Nixon, J Bishop, D Bradshaw, et al.
Pageof 4